Sarah Karlin-Smith of Pink Sheet reported via X: “RFK says HHS about to launch one of the biggest campaigns in HHS history to encourage Americans to use wearable health devices (like CGMs). His vision is every American wearing “wearable” in 4 years.” Shares of companies in the continuous glucose monitoring space moved higher intraday, including Tandem Diabetes (TNDM), DexCom (DXCM), Insulet (PODD), Abbott (ABT) and Medtronic (MDT).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNDM:
- Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
- Tandem Diabetes initiated with a Hold at Truist
- Tandem Diabetes announces agreement with Abbott to develop diabetes solutions
- Tandem Diabetes Care: Strategic Initiatives and Product Launches Drive Long-Term Growth Potential
- Balanced Outlook on Tandem Diabetes Care: Growth Opportunities Amid Strategic Challenges